Frontage Holdings Corp. (FGHQF)
0.175
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 357.36M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 16.82% |
| Valuation | |
| PE Ratio | 33.65 |
| PE Ratio (Forward) | |
| PS Ratio | 1.279 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 87.38% |
Profile
| Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. It operates through the USA and PRC segments. The USA segment includes the bioanalytical, chemistry, manufacturing and controls (CMC), drug metabolism and pharmacokinetic (DMPK), and safety and toxicology services in the USA. The PRC segment covers the bioanalytical and bioequivalence services. The company was founded by Song Li in 2001 and is headquartered in Exton, PA. |
| URL | http://www.frontagelab.com |
| Investor Relations URL | N/A |
| HQ State/Province | Pennsylvania |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Small Cap Core |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. It operates through the USA and PRC segments. The USA segment includes the bioanalytical, chemistry, manufacturing and controls (CMC), drug metabolism and pharmacokinetic (DMPK), and safety and toxicology services in the USA. The PRC segment covers the bioanalytical and bioequivalence services. The company was founded by Song Li in 2001 and is headquartered in Exton, PA. |
| URL | http://www.frontagelab.com |
| Investor Relations URL | N/A |
| HQ State/Province | Pennsylvania |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Small Cap Core |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |